Skye Bioscience

Skye Bioscience is a biotech company in San Diego, United States, founded in 2011. It has raised $153.0M across 5 rounds, most recently a $40.0M Private Equity in 2026 (est.).

Innovative Approach to Drug Development

Headquarters
San Diego
Employees
11–50
Founded
2011
Business Model
B2B
Total Funding
$153.0M
Last Round
$40.0M Private EquityJan 2026
Rounds
5

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

Indexed holds 5 funding rounds and 2 investors for this company. The full record is or through the API.

About

Skye Bioscience (Nasdaq: SKYE) is a clinical-stage biotechnology company focused on modulating the endocannabinoid system to develop new treatments for obesity and comorbid metabolic conditions. Founded in 2011 and based in San Diego, California, the company's mission is to contribute new mechanisms and drugs that build the mosaic of therapeutic approaches needed to serve patients with diverse metabolic needs, led by President and CEO Punit Dhillon.

Summary

It lists 11–50 employees. It has raised $153.0M in total across 5 rounds, most recently a $40.0M Private Equity round in 2026 (est.). Investors include 5AM Ventures and Versant Ventures.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Data from Indexed.vcUpdated
Private EquityPrivate Equity2026 (est.)
$40.0M

Sign up to see all 5 events

Funding: Seed through Private Equity. Amounts, valuations, and investors where available.

Investors

Similar Companies

Tiantan Biological / China Biologic (泰邦生物集团)

China's leading blood products manufacturer

Beijing, China1001–5000Biotech, Healthcare
Growth EquityTotal funding$5.1BAug 2022
Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Skye Bioscience on Indexed.vc
<a href="https://indexed.vc/companies/skye-bioscience"><img src="https://indexed.vc/api/badge/company/skye-bioscience" alt="Skye Bioscience on Indexed.vc" width="260" height="76" /></a>